Zhao Guobao

About

Guobao Zhao joined Chance Pharmaceuticals in early2021 as Senior Vice President responsible for Business Development and Strategy. Prior to Chance Pharmaceuticals, Mr. Zhao was Senior Vice President of Delian Capital,Mr. Zhao has led Delian’s investments in Amunix, Apexigen, MicuRx. In addition, Mr.Zhao also represents Delian as a Board member or observer on OnKure, Hummingbird Bioscience, and Chance Pharmaceuticals.Before joining Delian Capital, Mr. Zhao served as R&D Manager at CASI Pharmaceuticals (NASDAQ: CASI). Prior to CASI Pharmaceuticals, Mr. Zhao served as a Research Scientist atBioDuro.Mr. Zhao received his B.S. in Pharmacy and B.A. of English Languagefrom Huazhong University of Science and Technology, andhis M.S. in Medicinal Chemistry from AMMI and MBA from China Agricultural University.

Investment Focus

Location

Beijing, China